======= PHF15 =======
== Gene Information ==
* **Official Symbol**: JADE2
* **Official Name**: jade family PHD finger 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23338|23338]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NQC1|Q9NQC1]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PHF15&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PHF15|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/610515|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Component of the HBO1 complex which has a histone H4- specific acetyltransferase activity, a reduced activity toward histone H3 and is responsible for the bulk of histone H4 acetylation in vivo (PubMed:16387653). Acts as a E3 ubiquitin- protein ligase mediating the ubiquitination and subsequent proteasomal degradation of target protein histone demethylase KDM1A (PubMed:25018020). Also acts as a ubiquitin ligase E3 toward itself. Positive regulator of neurogenesis (By similarity). {ECO:0000250|UniProtKB:Q6ZQF7, ECO:0000269|PubMed:16387653}.
|PHD|
|EPL1|
|histone H4-K12 acetylation|
|histone H4-K8 acetylation|
|histone H4-K5 acetylation|
|histone H4-K16 acetylation|
|histone acetyltransferase complex|
|histone H3 acetylation|
|histone H4 acetylation|
|transferase activity|
|histone acetylation|
|internal peptidyl-lysine acetylation|
|peptidyl-lysine acetylation|
|internal protein amino acid acetylation|
|protein acetylation|
|protein acylation|
|peptidyl-lysine modification|
|histone modification|
|covalent chromatin modification|
|protein ubiquitination|
|chromatin organization|
|protein modification by small protein conjugation|
|peptidyl-amino acid modification|
|protein modification by small protein conjugation or removal|
|chromosome organization|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp29|Rapamycin 1μM R00 exp29]]|-2.26|
|[[:results:exp456|Benzoate 20000μM R08 exp456]]|-2.03|
|[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|-2|
|[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|-1.87|
|[[:results:exp18|Doxycycline 10μM R00 exp18]]|-1.86|
|[[:results:exp292|Menadione 5μM R06 exp292]]|-1.8|
|[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-1.74|
|[[:results:exp209|Deguelin 0.15μM R05 exp209]]|-1.71|
|[[:results:exp136|MS094 2μM R03 exp136]]|1.72|
|[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|2.08|
|[[:results:exp217|Mdivi-1 15μM R05 exp217]]|3.04|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 11192
* **Expression level (log2 read counts)**: 5.14
{{:chemogenomics:nalm6 dist.png?nolink |}}